Latest updates for Anupam Rasayan

Fresh curated links around Anupam Rasayan are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Anupam Rasayan in Focus After Acquiring Up to 48% Stake in Bliss GVS Pharma
  • Anupam Rasayan Targets 25–30% Revenue Recovery in FY27 Following Strategic Bliss GVS Pharma Acquisition
  • Bliss GVS Pharma Rallies 45% in 10 Sessions Via The Anupam Rasayan Deal and Two Other Catalysts

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

tradebrains.in /1 month ago

Anupam Rasayan in Focus After Acquiring Up to 48% Stake in Bliss GVS Pharma

Synopsis: Anupam Rasayan India Limited, a leading specialty chemicals company, announced on May 23, 2026, that it has signed a definitive agreement to acquire a 43.3% – 48.2% equit...

Read source
tradebrains.in /1 month ago

Anupam Rasayan Targets 25–30% Revenue Recovery in FY27 Following Strategic Bliss GVS Pharma Acquisition

Synopsis: Anupam Rasayan India Limited has highlighted significant growth opportunities arising from its proposed acquisition of Bliss GVS Pharma. The company expects revenue growt...

Read source
tradebrains.in /1 month ago

Bliss GVS Pharma Rallies 45% in 10 Sessions Via The Anupam Rasayan Deal and Two Other Catalysts

Synopsis: A rare convergence of a Rs. 2,198 crore control-change acquisition by Anupam Rasayan India, a fresh WHO-GMP certification for its Palghar manufacturing unit, and a 129 pe...

Read source
tradebrains.in /1 month ago

20% Upper Circuit: Pharma Stock Skyrockets After Announcing Strong Q4 Earnings

Synopsis: The share of this pharma company hit a 20 percent upper circuit after strong Q4 FY26 earnings driven by anesthetic demand, robust margins, and export-led growth momentum....

Read source
tradebrains.in /1 week ago

Why Did Balaji Amines and Alkyl Amines Shares Rally Up to 12% Today?

Synopsis:- The rally came after the Directorate General of Trade Remedies proposed a five-year anti-dumping duty on ethylene diamine imports from China, the EU, Saudi Arabia, and T...

Read source
businesstoday.in /6 hours ago

Himadri CMD Anurag Choudhary On Record Q1, ₹170 Crore Expansion & Speciality Chemicals Bet

Himadri Speciality Chemical delivered its highest-ever quarterly revenue in Q1FY27, posting robust growth in both revenue and net profit. In this exclusive conversation with Busine...

Read source
tradebrains.in /2 days ago

Specialty Chemical Stock to Buy Now for 30% Upside Potential

Synopsis: InCred initiated coverage on Privi Speciality Chemicals with an ADD rating and Rs. 4,796 target, citing capacity expansion, integrated operations, and long-term growth po...

Read source
tradebrains.in /3 weeks ago

Beyond ATBS: Can New Products and Capacity Expansion Power the Next Growth Cycle?

Synopsis: Companies’ consolidated revenue stood at Rs.2,280 crore in FY26, with EBITDA rising 13% YoY to Rs.707 crore and PAT growing 9% to Rs.444 crore. While topline growth remai...

Read source
tradebrains.in /1 month ago

Chemical Stock Hits 5% Upper Circuit After Reporting 348% QoQ Profit Growth in Q4

Synopsis: The stock of this company surged 5 percent after 348 percent profit growth in Q4 FY26, driven by strong turnaround, margin expansion, and improved operational performance...

Read source
businesstoday.in /1 month ago

IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma shares hit 52-week highs; what's next?

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...

Read source
tradebrains.in /5 days ago

How 1 Chemical Stock Is Riding Every Mega Trend From EV Battery Materials To Semiconductors 

Synopsis: Gujarat Fluorochemicals is trying to move beyond its traditional chemicals business by building exposure to EV battery materials, semiconductors, data centres, clean ener...

Read source
tradebrains.in /1 month ago

Chemical Stock Hits 5% Upper Circuit After Securing ₹35 Cr Orders from Solar Industries and Others

Synopsis: This micro-cap stock hit a 5 percent upper circuit after securing Rs 35 crore orders from Solar Industries and others, strengthening the order book and boosting visibilit...

Read source
thehindubusinessline.com /2 weeks ago

Ishan Dyes and Chemicals appoints A1 as primary dealer

Through this dealership, A-1 Ltd will gain access to a wider portfolio of sulphur based industrial chemicals including Sulphuric Acid, Oleum and Chloro Sulphonic Acid

Read source
tradebrains.in /1 month ago

Defence Stock to Buy Now for an Upside of 52%; Recommended by Anand Rathi

Synopsis: Anand Rathi has a Buy rating on Unimech Aerospace, citing strong growth prospects, expanding industry presence, improving profitability, and potential upside of nearly 52...

Read source
tradebrains.in /1 month ago

Chemical Stock Reports 161% QoQ Profit Growth and Announces ₹2,800 Cr Capex Plan

Synopsis:A Gujarat-based fertilizer and chemicals maker posted a sharp jump in quarterly profit, backed by better product prices and falling input costs, while pushing ahead with a...

Read source
tradebrains.in /2 weeks ago

13,000% Returns: Can This Ashish Kacholia Stock Deliver 400% Revenue Growth With ₹500 Cr Capex?

Synopsis: Ashish Kacholia-backed fluorochemical stock that turned every ₹1 lakh into ₹1.3 crore over a decade is now betting ₹495 crore on refrigerant gases and solar chemicals to...

Read source
tradebrains.in /1 month ago

A-1 Limited Hits Upper Circuit on Executing ₹35 Cr Industrial Supply Order Book

Synopsis: Small-cap chemical supplier A-1 Limited has announced fresh supply contracts worth nearly ₹35 crore from three established industrial customers across the explosives, pol...

Read source
tradebrains.in /2 days ago

Chemical Stock Quietly Diversifying into Animal Health and CDMO to Keep on Your Radar

Synopsis: A fine chemicals major built on pharmaceuticals and crop protection is now looking beyond both, betting on animal health, personal care, and specialty chemicals to power...

Read source
tradebrains.in /2 weeks ago

Chemical Stock: Can Engineering Polymers for EVs, Appliances, Electronics Drive Long-Term Growth?

Synopsis: An engineering polymer manufacturer is strengthening its domestic position while simultaneously expanding internationally through a Thailand acquisition. With ABS capacit...

Read source
tradebrains.in /1 month ago

Gujarat Fluorochemicals Share: Can EV Battery Chemicals Become the Next Big Revenue Engine?

Synopsis: A specialty chemical giant bets big on battery materials, even as early-stage losses weigh on consolidated earnings and the transition story unfolds. India’s energy trans...

Read source
businesstoday.in /1 month ago

Gland Pharma, Sun Pharmaceutical, Laurus Labs shares zoom up to 16% to hit 52-week highs; here's why

Gland Pharma jumped 15.85 per cent to Rs 2,164.40, while Sun Pharma climbed 1 per cent to Rs 1,896.90. Laurus Labs moved up 0.63 per cent to Rs 1,332.

Read source
tradebrains.in /2 weeks ago

3 Chemical Stocks That Are Quietly Becoming India’s Biggest Semiconductor Chip Supply Chain Winners

Synopsis: India’s semiconductor ambitions are finally moving from policy announcements to physical execution, but building a chip ecosystem requires far more than fabrication plant...

Read source
thehindubusinessline.com /1 week ago

Stocks to Watch Today: Supriya Lifescience, Rubicon Research, Fortis Healthcare, Fermenta Biotech

Customs Department has initiated probe against its general manager, sales and marketing officer Sreekant Sreedharan of Supriya Life

Read source
tradebrains.in /4 days ago

Gujarat Alkalies: Can This Chemical Stock More Than Double Its Revenue to ₹10,000 Cr by FY31?

Synopsis: A legacy chlor-alkali producer with a five-decade operating history is charting an ambitious growth path, aiming to multiply revenue several times over through capacity e...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Anupam Rasayan

tradebrains.in

Recent coverage from public sources
Public source

businesstoday.in

Recent coverage from public sources
Public source

thehindubusinessline.com

Recent coverage from public sources
Public source